PHILADELPHIA – Penn Medicine’s Gary Lichtenstein, MD, a professor of Medicine and Gary Wu, MD, the Ferdinand G. Weisbrod Professor in Gastroenterology were recently recognized by The Crohn’s & Colitis Foundation of America (CCFA) with 2015 Inflammatory Bowel Disease (IBD) Scientific Achievement Awards.
Lichtenstein, who also directs Penn’s Inflammatory Bowel Disease Center, was awarded the Scientific Achievement in IBD Clinical Research Award and Wu won the Scientific Achievement in Basic IBD Research Award.
Lichtenstein has led the Inflammatory Bowel Disease Center for 22 years. His current research has looked into investigational therapies for ulcerative colitis (UC) and Crohn’s disease treatments. He has served as the principal investigator in trials evaluating novel agents in the treatment of UC and Crohn’s disease.
Wu serves as the associate chief for research in Gastroentorology, the co-director of the Penn-CHOP Microbiome Program as well as the associate director of the Center for Molecular Studies in Digestive and Liver Disease at the University of Pennsylvania. He is also an elected member of the American Society for Clinical Investigation and the Association of American Physicians.
The awards were given out at the CCFA’s annual Advances in Inflammatory Bowel Diseases Conference in Orlando, Florida earlier this month.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $8.6 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.